Open access
Sep 2026
Regulatory T cells exhibit differential therapeutic effects across tissues during chronic autoimmune inflammation.
Current therapies for autoimmune diseases rely largely on non-specific immunosuppression, which can lead to adverse effects such as malignancy and severe infections. Treg-based therapies have therefore attracted attention as a more targeted approach, particularly in preventive or early-stage settings. However, their ef...
Yuji Nishimura, Yosuke Nagahata, Daiya Ohara et al.
· International Immunology · 0 citations